If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Dr. David Boulware is an infectious disease physician-scientist with formal training in public health, clinical trials, and tropical medicine.  As a translational researcher, Dr. Boulware combines his clinical research training with basic science investigations into disease pathogenesis. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved care.

Dr. Boulware’s current research is focused on improving the clinical outcomes of HIV-infected persons with meningitis.  Cryptococcal meningitis is the second most common AIDS-defining opportunistic infection in Sub-Saharan Africa and the most common cause of adult meningitis. Why Cryptococcus?  During 2016, cryptococcal meningitis accounts for ~70% of adult meningitis in Uganda. Even in the U.S., the estimated incidence of 1.1 hospitalizations for cryptococcal meningitis makes this more common than all causes of bacterial meningitis combined. Prevention with targeted cryptococcal antigen screening and preemptive therapy for early disseminated Cryptococcus infection is of great interest with ongoing clinical studies and trials. Diagnostics for TB meningitis have become an emerging area of interest and research.  Dr. Boulware has active research collaborations in Uganda, South Africa, Tanzania, and Ethiopia leading a multidisciplinary, international research team which is highly collaborative in working with others.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 6 Similar Profiles
Cryptococcal Meningitis Medicine & Life Sciences
HIV Medicine & Life Sciences
Immune Reconstitution Inflammatory Syndrome Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Uganda Medicine & Life Sciences
Antigens Medicine & Life Sciences
Meningitis Medicine & Life Sciences
Meningeal Tuberculosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2021

Capacity Building
Cryptococcosis
Research
Cryptococcal Meningitis
Fluconazole
Africa South of the Sahara
Therapeutics
Non-Randomized Controlled Trials
Meningitis
Acquired Immunodeficiency Syndrome
HIV

Research Output 2003 2019

Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing

Rajasingham, R., Wake, R. M., Beyene, T., Katende, A., Letang, E. & Boulware, D. R., Jan 1 2019, In : Journal of Clinical Microbiology. 57, 1, e01238.

Research output: Contribution to journalReview article

Cryptococcal Meningitis
Antigens
Meningitis
Point-of-Care Systems
HIV Antigens

Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies

Bahr, N. C., Panackal, A. A., Durkin, M. M., Smedema, M. L., Keown, W., Davis, T. E., Raymond-Guillen, L., Park, Y. D., Marr, K. A., Fries, B. C., Williamson, P. R., Boulware, D. R. & Wheat, L. J., Jan 1 2019, (Accepted/In press) In : Mycoses.

Research output: Contribution to journalArticle

Blastomyces
Coccidioides
Cryptococcal Meningitis
Histoplasma
Cerebrospinal Fluid

Epidemiology of non-traumatic spinal cord injury in Uganda: A single center, prospective study with MRI evaluation

Musubire, A. K., Meya, D. B., Katabira, E. T., Meyer, A. C. L., Bohjanen, P. R., Boulware, D. R. & Minja, F., Jan 15 2019, In : BMC Neurology. 19, 1, 10.

Research output: Contribution to journalArticle

Uganda
Spinal Cord Injuries
Epidemiology
Magnetic Resonance Imaging
Prospective Studies

Etiology of Sepsis in Uganda Using a Quantitative Polymerase Chain Reaction-based TaqMan Array Card

Moore, C. C., Jacob, S. T., Banura, P., Zhang, J., Stroup, S., Boulware, D. R., Scheld, W. M., Houpt, E. R. & Liu, J., Jan 7 2019, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68, 2, p. 266-272 7 p.

Research output: Contribution to journalArticle

Uganda
Sepsis
Polymerase Chain Reaction
Africa South of the Sahara
Odds Ratio

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis

Rajasingham, R., Meya, D. B., Greene, G. S., Jordan, A., Nakawuka, M., Chiller, T. M., Boulware, D. R. & Larson, B. A., Jan 1 2019, In : PloS one. 14, 1, e0210105.

Research output: Contribution to journalArticle

Uganda
cost effectiveness
Cost effectiveness
Cost-Benefit Analysis
Screening